Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Channels

Sticking to nooks and crannies

Drug design for voltage-gated ion channels has long been hampered by the absence of crystal structures and the challenge of achieving subtype selectivity. A combination of mutagenesis, electrophysiology and molecular modeling has led to the identification of a new side pocket binding site for the small molecule Psora-4 between the pore and the voltage-sensor domain of Kv1.5, offering opportunities to design allosteric ion channel modulators.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structural models of Psora-4 binding to Kv1.5 and PAP-1 binding to Kv1.3.

References

  1. Harmar, A.J. et al. Nucleic Acids Res. 37, D680–D685 (2009).

    Article  CAS  Google Scholar 

  2. Marzian, S. et al. Nat. Chem. Biol. 9, 507–513 (2013).

    Article  CAS  Google Scholar 

  3. Vennekamp, J. et al. Mol. Pharmacol. 65, 1364–1374 (2004).

    Article  CAS  Google Scholar 

  4. Schmitz, A. et al. Mol. Pharmacol. 68, 1254–1270 (2005).

    Article  CAS  Google Scholar 

  5. Long, S.B. et al. Nature 450, 376–382 (2007).

    Article  CAS  Google Scholar 

  6. Zimin, P.I. et al. Mol. Pharmacol. 78, 588–599 (2010).

    Article  CAS  Google Scholar 

  7. Payandeh, J. et al. Nature 475, 353–358 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Heike Wulff or Vladimir Yarov-Yarovoy.

Ethics declarations

Competing interests

H.W. is an inventor on a University of California patent claiming PAP-1 for immunosuppression. This patent has been licensed by Airmid, Inc., a start-up company for which H.W. is a scientific founder. Airmid has licensed on the PAP-1 patent to Circassia Ltd. (Oxford, UK) for development as a topical for psoriasis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wulff, H., Yarov-Yarovoy, V. Sticking to nooks and crannies. Nat Chem Biol 9, 473–474 (2013). https://doi.org/10.1038/nchembio.1292

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.1292

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing